Insider · CIK 0001838114

Jimenez Freddy A.

Reports to the SEC for 1 company · HAMPTON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001838114

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP & GENERAL COUNSEL	AAward	+93K sh	—	—	93,000
2025-12-04	CLDXCelldex Therapeutics, Inc.S Sale	SVP & GENERAL COUNSEL	SSale	−4,166 sh	$29.09	−$121K	30,796
2025-08-13	CLDXCelldex Therapeutics, Inc.S Sale	SVP & GENERAL COUNSEL	SSale	−341 sh	$23.95	−$8,167.461	35,392
2025-08-13	CLDXCelldex Therapeutics, Inc.S Sale	SVP & GENERAL COUNSEL	SSale	−430 sh	$25.41	−$10.9K	34,962
2025-06-05	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP & GENERAL COUNSEL	AAward	+75K sh	—	—	75,000
2024-06-13	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP & GENERAL COUNSEL	AAward	+75K sh	—	—	75,000
2024-06-05	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP & GENERAL COUNSEL	MExercise/Conversion	+9,540 sh	$10.38	+$99K	35,464
2024-06-05	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP & GENERAL COUNSEL	MExercise/Conversion	−9,540 sh	—	—	18,454
2024-06-03	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP & GENERAL COUNSEL	MExercise/Conversion	+8,006 sh	$10.38	+$83.1K	33,930
2024-06-03	CLDXCelldex Therapeutics, Inc.S Sale	SVP & GENERAL COUNSEL	SSale	−8,006 sh	$33.60	−$269K	25,924
2024-06-03	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP & GENERAL COUNSEL	MExercise/Conversion	−8,006 sh	—	—	27,994
2024-02-13	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP & GENERAL COUNSEL	MExercise/Conversion	+4,166 sh	$9.02	+$37.6K	5,924
2024-02-13	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP & GENERAL COUNSEL	MExercise/Conversion	+20K sh	$2.78	+$55.6K	25,924
2024-02-13	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP & GENERAL COUNSEL	MExercise/Conversion	−4,166 sh	—	—	0
2024-02-13	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP & GENERAL COUNSEL	MExercise/Conversion	−20K sh	—	—	0
2023-06-15	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP & GENERAL COUNSEL	AAward	+74K sh	—	—	74,000
2022-06-16	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP & GENERAL COUNSEL	AAward	+73K sh	—	—	73,000
2021-08-11	CLDXCelldex Therapeutics, Inc.P Purchase	SVP & GENERAL COUNSEL	PPurchase	+430 sh	$46.28	+$19.9K	430
2021-06-17	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP & GENERAL COUNSEL	AAward	+73K sh	—	—	73,000

Recent filings

Accepted (ET)
Jun 294
Jimenez Freddy A.0001838114-26-000002
SEC(opens sec.gov)
Dec 84
Jimenez Freddy A.0001838114-25-000007
SEC(opens sec.gov)
Aug 154
Jimenez Freddy A.0001415889-25-022069
SEC(opens sec.gov)
Jun 94
Jimenez Freddy A.0001415889-25-016244
SEC(opens sec.gov)
Jun 174
Jimenez Freddy A.0001415889-24-017190
SEC(opens sec.gov)
Jun 74
Jimenez Freddy A.0001415889-24-015950
SEC(opens sec.gov)
Jun 54
Jimenez Freddy A.0001415889-24-015542
SEC(opens sec.gov)
Feb 154
Jimenez Freddy A.0001415889-24-003891
SEC(opens sec.gov)
Jun 204
Jimenez Freddy A.0001415889-23-010045
SEC(opens sec.gov)
Jun 174
Jimenez Freddy A.0001415889-22-006732
SEC(opens sec.gov)
Aug 134
Jimenez Freddy A.0001179110-21-008163
SEC(opens sec.gov)
Jun 214
Jimenez Freddy A.0001179110-21-006912
SEC(opens sec.gov)

Companies

Celldex Therapeutics, Inc.SVP & GENERAL COUNSELCLDX

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827